Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Wave Life Sciences (WVE) Receivables: 2017-2024

Historic Receivables for Wave Life Sciences (WVE) over the last 6 years, with Dec 2024 value amounting to $1.4 million.

  • Wave Life Sciences' Receivables was N/A to $10.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $14.3 million, marking a year-over-year change of. This contributed to the annual value of $1.4 million for FY2024, which is 93.26% down from last year.
  • Per Wave Life Sciences' latest filing, its Receivables stood at $1.4 million for FY2024, which was down 93.26% from $21.1 million recorded in FY2023.
  • In the past 5 years, Wave Life Sciences' Receivables ranged from a high of $60.0 million in FY2020 and a low of $1.4 million during FY2024.
  • In the last 2 years, Wave Life Sciences' Receivables had a median value of $11.3 million in 2023 and averaged $11.3 million.
  • Data for Wave Life Sciences' Receivables shows a maximum YoY tumbled of 93.26% (in 2024) over the last 5 years.
  • Yearly analysis of 3 years shows Wave Life Sciences' Receivables stood at $60.0 million in 2020, then reached $21.1 million in 2023, then tumbled by 93.26% to $1.4 million in 2024.